Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 24, 2005

View Archived Issues

New data on the pharmacokinetics of 667-Coumate in rats

Enrollment completed in phase II PAOD trial of NCX-4016

Sention to develop mGluR antagonists for Fragile X mental retardation

Jerini and Alcon collaborate on novel ophthalmology drugs

Novartis grants Meda European rights to Cibacen and Cibadrex

Novartis: pipeline review

Novel TRPV1 antagonist effective in animal model of inflammatory pain

Efficacy of R-135853 in mouse candidiasis

Researchers at Leiden University synthesize a novel ENT1 inhibitor

Rigel and Pfizer sign collaborative and license agreement for respiratory diseases

GenVec signs malaria vaccine contract with Department of Defense

Phase I study investigates pralatrexate in NSCLC

Copernicus receives award to advance genetic therapy for cystic fibrosis

Pegasys receives positive opinion in E.U. for hepatitis B

Antiinflammatory compounds described in a patent

Scientists at Pfizer claim beta2-adrenoceptor agonists for respiratory diseases

Novel gamma-secretase inhibitors for the treatment of Alzheimer's disease reported by Roche

Agents for the treatment of estrogen-dependent diseases described in a patent

New anticoagulant agents from Bayer

Several GSK and Pliva patents cover antibacterial agents

Depression reported to reduce the efficacy of IFN-alpha plus ribavirin in hepatitis C

Zolmitriptan nasal spray provides effective total pain relief in migraine patients

Improved gastrointestinal recovery found with MNTX after abdominal surgery

Update on the efficacy and safety of viramidine in chronic hepatitis C

Good safety profile found for PYM-50028 in AD patients

VRPs expressing HER2/neu prevent breast cancer growth and tumorigenesis in mice

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...